CORT has been in the news 395% more than usual
Mar 03, 2026, 3:32 PM
-1.92%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
CORT has been in the news recently: Corcept Therapeutics is facing multiple class action lawsuits from various law firms for allegedly misleading investors and ignoring FDA warnings between October 31, 2024, and December 30, 2025. The company's stock experienced a significant decline, dropping 50% from $70.20 to $34.80, prompting legal actions for potential compensation to affected shareholders.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.